National Atomic Company Kazatomprom JSC (KZAP) Q2 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 TU earnings summary
3 Aug, 2026Executive summary
Second quarter and half-year 2026 update highlights operational and trading results, with a focus on uranium market developments and company performance.
Global nuclear sector saw major investments, regulatory milestones, and new project launches, supporting robust uranium demand.
Company completed 2025 dividend payment and maintained Board composition, with a partial bond redemption executed.
Market and industry conditions
U.S. government approved $17.5 billion in loans for domestic nuclear supply chain, supporting new reactor builds.
Significant progress in SMR projects in the U.S., Russia, Uzbekistan, and the UK, with new plants and regulatory approvals.
UK banned Russian-origin uranium imports, with exemptions for certain cases; Australia and India expanded uranium trade.
New uranium mining projects launched in Mongolia, Uzbekistan, Canada, and the U.S.; Cameco resumed Cigar Lake operations after a brief suspension.
Uranium spot price averaged $85.98/lb in 1H2026, up from $69.11/lb in 1H2025; spot transaction volumes rose 19% year-over-year.
Long-term contract volumes increased to 32.5 million lbs in 1H2026, with average long-term price up $15.50/lb year-over-year to $95.50/lb.
Financial highlights
Group U3O8 production (100% basis) rose 8% in Q2 and 9% in 1H2026 year-over-year; attributable production up 10% for both periods.
Group U3O8 sales volume up 19% in Q2 and flat in 1H2026; KAP sales volume up 3% in Q2 but down 13% in 1H2026 due to delivery timing.
Group average realized price increased 17% in Q2 and 16% in 1H2026; KAP average realized price up 14% in Q2 and 13% in 1H2026.
2025 dividend of KZT 335.16 billion paid to shareholders in July 2026.
Latest events from National Atomic Company Kazatomprom JSC
- Revenue and profit fell on lower uranium sales, but a major dividend was approved.KZAP
Q1 2026 - Production up, sales down, prices higher; 2026 guidance steady amid robust nuclear demand.KZAP
Q1 2026 TU - Record uranium output and resilient financials set the stage for higher 2026 growth.KZAP
Q4 2025 - Production and sales volumes increased in 2025, but realized prices declined year-over-year.KZAP
Q4 2025 TU - Revenue up 4.7% but net profit down on lower uranium prices and higher costs.KZAP
Q3 2025 - Revenue and profits rose on higher uranium prices, but net profit fell due to a prior one-off gain.KZAP
Q2 2025 - Production up, prices down, and 2025 guidance steady amid robust global nuclear demand.KZAP
Q2 2025 TU - Production up, sales down, new European deals, and robust dividend amid volatile uranium prices.KZAP
Q1 2025 - Net profit up 27% year-over-year; 2025 production guidance cut amid sulfuric acid constraints.KZAP
Q2 2024